Skip to main content

Table 1 Clinical characteristics of patients with MSA and healthy controls in microarray analysis

From: Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson’s disease

 

N

Female

Male

Age, yr. (mean ± S.E.)

Disease duration, yr. (mean ± S.E.)

UMSARS (mean ± S.E.)

Part 1

Part 2

Part 3 (ΔsBP)

Part 3 (ΔdBP)

Part 4

MSA

13

7 (53.8%)

6 (46.2%)

62.64 ± 1.97

2.67 ± 0.30

18.18 ± 1.45

16.45 ± 2.46

−28.15 ± 7.16

−9.62 ± 4.81

2.36 ± 0.37

Control

6

3 (50.0%)

3 (50.0%)

60.67 ± 0.80

–

–

–

–

–

–

  1. MSA multiple system atrophy, UMSARS Unified Multiple System Atrophy Rating Scale, ΔsBP systolic blood pressure reduction on standing, ΔdBP diastolic blood pressure reduction on standing, S.E. standard error
Back to article page

Molecular Brain

ISSN: 1756-6606